Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 285.60 -4.14 (1.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.74 | 52 Week High | $139.79 | |||
| Open | $287.41 | 52 Week Low | $82.07 | |||
| Day High | $290.00 | P/E | 664.19 | |||
| Day Low | $285.47 | EPS | $0.43 | |||
| Volume | 132,390 | |||||

